SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that Anthem has issued a positive coverage decision for the Prosigna® Breast Cancer Gene Signature Assay. This positive coverage decision is in line with updated ASCO guidelines released in February 2016. The ASCO guidelines recommend the use of […]
CellSystems and ATERA to expand their on-going collaboration by co-marketing ATERA’s ‘on demand’ advanced 3D-tissue model R&D and specialized contract research services. On July 3, 2017, CellSystems Biotechnologie Vertrieb GmbH (Troisdorf, Germany) and ATERA SAS (Sophia Antipolis, France) announced a close collaboration for the commercialization of the epiCS® human skin models, including human epidermis, tanned epidermis and full thickness skin. […]
Oxford Nanopore has released a new basecaller, Albacore v2.0.1, that identifies DNA sequences directly from raw data, rather than utilising an intermediary stage called ‘event detection’. This upgrade enhances accuracy of the single-read sequence data, contributing to high consensus accuracy for nanopore sequence data. Moving to raw basecalling also opens up opportunities for further improvements […]
LANSING, Mich. — Neogen Corporation (NASDAQ: NEOG) announced today that it has acquired the assets of The University of Queensland Animal Genetics Laboratory (AGL) — the leading animal genomics laboratory in Australia, a country with large cattle and sheep markets. The acquisition of AGL is intended to help accelerate the growth of Neogen’s animal genomics […]
M2’s Scientists to Leverage PerkinElmer’s Robotic Cellular Screening Workstations for Insights into Materials and BioMedical Sciences WHAT: PerkinElmer, Inc. a global leader committed to innovating for a healthier world, today announced that researchers at Australia’s new M2 medtech R&D initiative will utilize its cell::explorer™ robotic workstations for cell cultivation and phenotypic screening. WHEN & WHERE: […]
Seoul, Korea – Seegene, the world’s leading developer of multiplex molecular technologies and assays, announced that it has recently signed collaborative contracts with 30 general hospitals and reference laboratories across 15 nations for the co-development of ‘Project 100’ products. Contracting parties are mostly the largest commercial labs in the country, university hospitals, and institutions with […]
Company expands portfolio of next-generation sequencing immuno-oncology and liquid biopsy assays to meet demand for a multi-disciplinary approach to cancer research AMSTERDAM and MADRID and CARLSBAD, Calif. — Thermo Fisher Scientific has formed the Immuno-Oncology Consortium to drive adoption of highly sensitive, next-generation sequencing (NGS) clinical research panels designed to help identify predictive and prognostic biomarkers associated with cancer immunotherapy. Recognizing […]
AMSBIO announces the availability of StemFit® Basic02 feeder-free stem cell culture media. Stem cells and genome editing offer exciting opportunities within regenerative medicine. However, any clinical application of stem cells requires strict regulation to ensure that the cells are not exposed to animal derived products. StemFit® Basic02 is a xeno-free, defined medium for human pluripotent stem […]
Kymriah™ (tisagenlecleucel, formerly CTL019), the first FDA-approved CAR-T cell therapy, uses CTS Dynabeads CD3/CD28 spherical beads to isolate, activate and expand T cells WALTHAM, Mass. — The U.S. Food and Drug Administration (FDA) has approved a new cell therapy for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia […]
Recent market developments inspire ExcitePCR management to expand its product strategy to a planned rollout of a FireflyDX family of realtime pathogen detection systems, with the FireflyDX-Portable launch scheduled for the summer of 2018 and the FireflyDX-Handheld targeted for availability in 2019 Pleasanton, Calif. ExcitePCR™ today announced the FireflyDX-Portable™, a rechargeable bookbag-sized realtime pathogen detection […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
